Actively Recruiting
The MARVIN Chatbots to Provide Information for Different Health Conditions
Led by McGill University Health Centre/Research Institute of the McGill University Health Centre · Updated on 2024-03-06
400
Participants Needed
2
Research Sites
565 weeks
Total Duration
On this page
Sponsors
M
McGill University Health Centre/Research Institute of the McGill University Health Centre
Lead Sponsor
C
Centre hospitalier de l'Université de Montréal (CHUM)
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research is a continuation of a usability study with the MARVIN chatbot. The investigators aim to adapt the MARVIN chatbot to open it to other health domains (e.g. breast cancer) and populations (e.g. pharmacists). Therefore, this protocol constitutes a master research protocol that will englobe different research projects with individual chatbots. The investigators adopt an adaptive platform trial design, which will allow flexibility in handling multiple interventions adapted to different populations while retaining the characteristics of a platform trial design allowing early withdrawal of ineffective trial arms based on interim data (implementation outcomes) and introduction of new trial arms.
CONDITIONS
Official Title
The MARVIN Chatbots to Provide Information for Different Health Conditions
Who Can Participate
Eligibility Criteria
You may qualify if you...
Inclusion Criteria for all objectives:
- being 14 years or older;
- being fluent in English and/or French;
- being able to understand the requirements of study participation and provide informed consent during the duration of the study;
- having access to a smartphone, tablet, or computer at home/at workplace;
- having access to an internet connection at home or data plan on their device.
Inclusion Criteria Specific to objectives 2 and 3:
- accept to use a Facebook Messenger-based Chatbot;
- accept to use or create a personal Facebook account;
- accept Facebook's privacy and data security policies.
Exclusion Criteria:
- not meeting the inclusion criteria
- any reason, in the opinion of the investigator, which would make the candidate inappropriate for participation in an investigative study involving a chatbot (e.g., cognitive deficit)
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Centre hospitalier de l'Université de Montréal (CHUM)
Montreal, Quebec, Canada, H2X 3E4
Actively Recruiting
2
McGill University Health Centre (MUHC)
Montreal, Quebec, Canada, H4A 3J1
Actively Recruiting
Research Team
B
Bertrand Lebouché, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here